US Patent Issued to The Regents of the University of California on Nov. 3 for "Cancer progression risk assessment by microvascular phenotype" (California Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,354, issued on Nov. 3, was assigned to The Regents of the University of California (Oakland, Calif.).

"Cancer progression risk assessment by microvascular phenotype" was invented by Thea Tlsty (San Francisco), Joseph Caruso (San Francisco), Karla Kerlikowske (San Anselmo, Calif.), Annette Molinaro (San Francisco) and RosaAnna DeFilippis (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Repression of CD36 vasculature in stromal tissues surrounding a pre-cancerous lesion provides is indicative of increased risk of subsequent progression to invasive cancer. Methods of assessing progression risk by measuring the abundance of CD36 vasculature ...